Clinical Trials Browser

Immunotherapy, Adoptive × Gastrointestinal × 90 days × Clear all

NCT05003895 2026-03-03

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

Phase 1 Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms